Global Blood Therapeutics, Inc.
(NASDAQ : GBT)

( )
GBT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 2.76%164.450.0%$1384.40m
AMGNAmgen, Inc. 0.00%249.621.3%$691.62m
NVAXNovavax, Inc. 2.66%206.7080.0%$586.32m
SNSSSunesis Pharmaceuticals, Inc. 0.00%7.880.7%$550.84m
ILMNIllumina, Inc. 0.00%398.073.5%$515.02m
GILDGilead Sciences, Inc. 0.00%65.301.0%$465.35m
REGNRegeneron Pharmaceuticals, Inc. 0.00%481.162.7%$431.65m
VRTXVertex Pharmaceuticals, Inc. 0.00%217.131.9%$373.76m
ALXNAlexion Pharmaceuticals, Inc. 0.00%155.292.0%$316.00m
BIIBBiogen, Inc. 0.00%265.791.7%$265.53m
BNTXBioNTech SE 1.92%135.150.0%$240.87m
EXASEXACT Sciences Corp. 0.00%127.1418.4%$192.79m
CRSPCRISPR Therapeutics AG 1.54%125.000.6%$179.63m
NBIXNeurocrine Biosciences, Inc. 0.00%95.054.9%$177.79m
TWSTTwist Bioscience Corp. -0.32%141.570.0%$150.49m

Company Profile

Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.